Dr. Evens is Adjunct Research Professor & biotechnology consultant at Tufts University, School of Medicine, Center for the Study of Drug Development. Dr. Evens is President of MAPS 4 Biotec, Inc, his consulting company to biotechnology industry for strategy, planning, & operations of medical affairs groups for drug research, medical education, medical liaisons, provider/patient services, and product launch. Clients have included Amgen, Amylin, Bertek, Cheladerm, Oragenics, Pharmacyclics, plus advising Banyan, Prevacus, MLM, Nanotherapeutics, and St. Charles. He is editor of 2 books, "Drug & Biological Development, From Molecule to Product & Beyond", Springer Publisher, 2007; BioPharma Language, Acronyms and Terms, Jones and Bartlett Publisher, 2009. Dr. Evens also authored 16 review articles and book chapters in biotechnology. Dr. Evens was professor of pharmacy at University of Florida and then University of Pacific for 15 years focused on biotechnology education. At Amgen (13 years, worldwide leader in bio